156 related articles for article (PubMed ID: 31218947)
1. Bioactivities of Natural Catalpol Derivatives.
Zhang LQ; Chen KX; Li YM
Curr Med Chem; 2019; 26(33):6149-6173. PubMed ID: 31218947
[TBL] [Abstract][Full Text] [Related]
2. Anti-Inflammatory Activity Comparison among Scropoliosides-Catalpol Derivatives with 6-O-Substituted Cinnamyl Moieties.
Zhu T; Zhang L; Ling S; Qian F; Li Y; Xu JW
Molecules; 2015 Nov; 20(11):19823-36. PubMed ID: 26540037
[TBL] [Abstract][Full Text] [Related]
3. Catalpol Inhibits Homocysteine-induced Oxidation and Inflammation via Inhibiting Nox4/NF-κB and GRP78/PERK Pathways in Human Aorta Endothelial Cells.
Hu H; Wang C; Jin Y; Meng Q; Liu Q; Liu Z; Liu K; Liu X; Sun H
Inflammation; 2019 Feb; 42(1):64-80. PubMed ID: 30315526
[TBL] [Abstract][Full Text] [Related]
4. Amelioration by catalpol of atherosclerotic lesions in hypercholesterolemic rabbits.
Liu JY; Zhang DJ
Planta Med; 2015 Feb; 81(3):175-84. PubMed ID: 25671384
[TBL] [Abstract][Full Text] [Related]
5. Review of the Ethnopharmacology, Phytochemistry, and Pharmacology of the Genus
Xue H; Chen KX; Zhang LQ; Li YM
Am J Chin Med; 2019; 47(6):1193-1221. PubMed ID: 31488038
[No Abstract] [Full Text] [Related]
6. Catalpol inhibits LPS plus IFN-γ-induced inflammatory response in astrocytes primary cultures.
Bi J; Jiang B; Zorn A; Zhao RG; Liu P; An LJ
Toxicol In Vitro; 2013 Mar; 27(2):543-50. PubMed ID: 23164921
[TBL] [Abstract][Full Text] [Related]
7. Catalpol ameliorates high-fat diet-induced insulin resistance and adipose tissue inflammation by suppressing the JNK and NF-κB pathways.
Zhou J; Xu G; Ma S; Li F; Yuan M; Xu H; Huang K
Biochem Biophys Res Commun; 2015 Nov; 467(4):853-8. PubMed ID: 26474703
[TBL] [Abstract][Full Text] [Related]
8. Anti-inflammatory effect and mechanism of catalpol in various inflammatory diseases.
Liu J; Liu S; Yu M; Li J; Xie Z; Gao B; Liu Y
Drug Dev Res; 2023 Nov; 84(7):1376-1394. PubMed ID: 37534768
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotection of Catalpol for Experimental Acute Focal Ischemic Stroke: Preclinical Evidence and Possible Mechanisms of Antioxidation, Anti-Inflammation, and Antiapoptosis.
Zheng XW; Yang WT; Chen S; Xu QQ; Shan CS; Zheng GQ; Ruan JC
Oxid Med Cell Longev; 2017; 2017():5058609. PubMed ID: 28785376
[TBL] [Abstract][Full Text] [Related]
10. Catalpol suppresses advanced glycation end-products-induced inflammatory responses through inhibition of reactive oxygen species in human monocytic THP-1 cells.
Choi HJ; Jang HJ; Chung TW; Jeong SI; Cha J; Choi JY; Han CW; Jang YS; Joo M; Jeong HS; Ha KT
Fitoterapia; 2013 Apr; 86():19-28. PubMed ID: 23376161
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of catalpol on lipopolysaccharide-induced acute lung injury in mice.
Fu K; Piao T; Wang M; Zhang J; Jiang J; Wang X; Liu H
Int Immunopharmacol; 2014 Dec; 23(2):400-6. PubMed ID: 25063711
[TBL] [Abstract][Full Text] [Related]
12. Iridoid glucosides and a C₁₃-norisoprenoid from Lamiophlomis rotata and their effects on NF-κB activation.
Zhang F; Wu ZJ; Sun LN; Wang J; Tao X; Chen WS
Bioorg Med Chem Lett; 2012 Jul; 22(13):4447-52. PubMed ID: 22664131
[TBL] [Abstract][Full Text] [Related]
13. Two New Iridoid Glucosides from the Whole Plant of
Sun S; Fu J; Liu K; Dai M; Li Y; Liu Y; Ma S; Qu J
Molecules; 2021 Jul; 26(14):. PubMed ID: 34299477
[TBL] [Abstract][Full Text] [Related]
14. Catalpol attenuates lipopolysaccharide-induced inflammatory responses in BV2 microglia through inhibiting the TLR4-mediated NF-κB pathway.
Choi YH
Gen Physiol Biophys; 2019 Mar; 38(2):111-122. PubMed ID: 30806632
[TBL] [Abstract][Full Text] [Related]
15. Scropolioside B inhibits IL-1β and cytokines expression through NF-κB and inflammasome NLRP3 pathways.
Zhu T; Zhang L; Ling S; Duan J; Qian F; Li Y; Xu JW
Mediators Inflamm; 2014; 2014():819053. PubMed ID: 25386048
[TBL] [Abstract][Full Text] [Related]
16. Effects of catalpol on ATPase and amino acids in gerbils with cerebral ischemia/reperfusion injury.
Liu YR; Lei RY; Wang CE; Zhang BA; Lu H; Zhu HC; Zhang GB
Neurol Sci; 2014 Aug; 35(8):1229-33. PubMed ID: 24584634
[TBL] [Abstract][Full Text] [Related]
17. Molecular and Biochemical Pathways of Catalpol in Alleviating Diabetes Mellitus and Its Complications.
Bhattamisra SK; Koh HM; Lim SY; Choudhury H; Pandey M
Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33672590
[TBL] [Abstract][Full Text] [Related]
18. Catalpol: a potential therapeutic for neurodegenerative diseases.
Jiang B; Shen RF; Bi J; Tian XS; Hinchliffe T; Xia Y
Curr Med Chem; 2015; 22(10):1278-91. PubMed ID: 25620103
[TBL] [Abstract][Full Text] [Related]
19. Autophagy inhibition attenuates the induction of anti-inflammatory effect of catalpol in liver fibrosis.
Liu Z; Zhu P; Zhang L; Xiong B; Tao J; Guan W; Li C; Chen C; Gu J; Duanmu J; Zhang W
Biomed Pharmacother; 2018 Jul; 103():1262-1271. PubMed ID: 29864907
[TBL] [Abstract][Full Text] [Related]
20. Insights into the mechanism of natural terpenoids as NF-κB inhibitors: an overview on their anticancer potential.
Jain H; Dhingra N; Narsinghani T; Sharma R
Exp Oncol; 2016 Sep; 38(3):158-68. PubMed ID: 27685522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
